Designing a robust lateral flow test specification for high-volume manufacture

The COVID-19 pandemic has seen the global mobilisation of diagnostics: predominantly lateral flow rapid tests and lab-based molecular tests. The deployment of laboratory molecular testing has highlighted the barriers in reaching the widest patient cohort and delivering test results as fast as possible. Abingdon Health spoke with… Read More
COVID-19 increased the need to deploy novel diagnostics in great numbers and quickly. Companies mobilised capabilities and capacities to ensure those in most need have access to testing solutions. Everyone has now heard of PCR’s (Polymerase Chain Reaction) ability to copy and amplify specific nucleic acid sequences. This revolutionised molecular… Read More
Learn the crucial reasons why scale-up should be considered early in the assay development process. Read More
Aiding supply and demand in potential disruptive periods such as the current COVID-19 outbreak. Read More
Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering. Read More
Learn about some of the technical considerations for selecting antibodies during lateral flow assay development. Read More
Nina Garrett, Head of Assay Development, looks at the technical considerations when starting a lateral flow project. Read More
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market. Read More